Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

https://www.soho2020.com/

 

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
U

2020 SOHO Updates on Anemia in MDS: How Does Luspatercept Affect RBC-TI? What Is the Treatment Response With Novel Agent Imetelstat?

By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Uwe Platzbecker
By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Uwe Platzbecker
154 views
November 9, 2020
SOHO 2020 on-demand content is available through January 12, 2021. To access the virtual environment, ...
read more ↘
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
MDS and MPN
09:07

2020 SOHO Update on MDS: Characteristics and Outcomes of SF3B1 Mutat…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

V. Volpe

164 views
14:48

2020 SOHO Update on IDH Inhibitors in MDS: How Common Are IDH 1/2 Mu…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

C. DiNardo

17 views
13:30

2020 SOHO Updates on Anemia in MDS: How Does Luspatercept Affect RBC…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

U. Platzbecker

154 views
15:33

2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/C…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Garcia-Manero

165 views
15:52

2020 SOHO Updates on MDS: What Is the Safety and Efficacy of Ven+Aza…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

A. Zeidan

127 views
17:02

2020 SOHO Updates on TP53 in MDS: What Is the Correlation of VAF and…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Sallman

139 views
18:11

2020 SOHO Updates on MDS: How Do TP53 Mutations Impact Prognosis in …

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Sallman

15 views
19:05

2020 SOHO Updates on ET: What Does the Diagnostic Algorithm Look Lik…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

A. Tefferi

76 views
09:44

Next Questions in MF in 2020: What Is MIPSS70-Plus Risk Score? What …

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

P. Bose

24 views
10:10

2020 SOHO Updates on MDS: What Is the Proposed Treatment Algorithm f…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Garcia-Manero

21 views
16:23

2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R. Rampal

358 views
12:50

2020 SOHO Highlights on Myelofibrosis: How Can We Improve Survival A…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

U. Popat

151 views
09:59

2020 SOHO Updates on Myelofibrosis: What Are the Long-Term Outcomes …

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

J. Joseph

104 views
17:07

73 y/o Male With Polycythemia Vera With JAK2 V617F Mutation: How Doe…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

L. Michaelis

65 views
15:11

34 y/o Female With JAK2 V617F Mutated Polycythemia Vera: What PV Tre…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Hobbs

181 views
16:58

2020 SOHO Updates on Myelofibrosis: What Are the Response Rates With…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

S. Verstovsek

157 views